
“A psychological placebo”: Why this hedge fund manager is betting against drug companies in the race for a Covid vaccine
The frantic hunt for an effective vaccine against coronavirus could leave some pharmaceutical companies highly exposed in a fiercely competitive race – and UK hedge fund Argonaut Capital is weighing in with several key bets against the sector.






